D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Amazon
AMZN
|
+$490M |
| 2 |
Microsoft
MSFT
|
+$461M |
| 3 |
Estee Lauder
EL
|
+$422M |
| 4 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$239M |
| 5 |
Nike
NKE
|
+$234M |
Top Sells
| 1 |
Walmart
WMT
|
+$585M |
| 2 |
Tesla
TSLA
|
+$470M |
| 3 |
NVIDIA
NVDA
|
+$431M |
| 4 |
Eli Lilly
LLY
|
+$360M |
| 5 |
T-Mobile US
TMUS
|
+$299M |
Sector Composition
| 1 | Technology | 26.44% |
| 2 | Consumer Discretionary | 14.71% |
| 3 | Healthcare | 12.37% |
| 4 | Financials | 8.93% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Voyager Therapeutics
VYGR
$232M
| $4.85M | 0.01% |
626,123
-321,850
| -34% | -$2.49M |
|
1077
MiMedx Group
MDXG
$1.03B
| $4.84M | 0.01% |
663,713
-311,217
| -32% | -$2.27M |
|
1078
fuboTV
FUBO
$1.46B
| $4.84M | 0.01% |
1,811,684
-2,469,497
| -58% | -$6.59M |
|
1079
Core Laboratories
CLB
$581M
| $4.83M | 0.01% |
201,327
+98,413
| +96% | +$2.36M |
|
1080
Mobileye
MBLY
$11.1B
| $4.82M | 0.01% |
116,122
-349,311
| -75% | -$14.5M |
|
1081
Pacira BioSciences
PCRX
$1.22B
| $4.82M | 0.01% |
157,062
+151,753
| +2,858% | +$4.66M |
|
1082
Olo Inc
OLO
$1.74B
| $4.82M | 0.01% |
794,748
+138,659
| +21% | +$840K |
|
1083
Popular Inc
BPOP
$8.34B
| $4.82M | 0.01% |
76,419
+3,273
| +4% | +$206K |
|
1084
Target
TGT
$40.9B
| $4.81M | 0.01% |
43,511
-17,445
| -29% | -$1.93M |
|
1085
Masco
MAS
$15.4B
| $4.79M | 0.01% |
89,539
+30,055
| +51% | +$1.61M |
|
1086
First Foundation Inc
FFWM
$493M
| $4.77M | 0.01% |
784,011
-372,839
| -32% | -$2.27M |
|
1087
Ambac
AMBC
$413M
| $4.76M | 0.01% |
394,977
+64,908
| +20% | +$783K |
|
1088
Murphy USA
MUSA
$7.53B
| $4.76M | 0.01% |
13,924
-40,450
| -74% | -$13.8M |
|
1089
Dycom Industries
DY
$7.47B
| $4.76M | 0.01% |
53,435
-13,794
| -21% | -$1.23M |
|
1090
HCA Healthcare
HCA
$94.8B
| $4.75M | 0.01% |
19,300
-75,549
| -80% | -$18.6M |
|
|
OSG
1091
DELISTED
Overseas Shipholding Group Inc.
OSG
| $4.75M | 0.01% |
1,081,204
-174,155
| -14% | -$765K |
|
1092
Blue Owl Capital
OBDC
$7.23B
| $4.75M | 0.01% |
342,683
+303,922
| +784% | +$4.21M |
|
1093
Turning Point Brands
TPB
$1.84B
| $4.73M | ﹤0.01% |
204,905
-9,379
| -4% | -$217K |
|
1094
CareTrust REIT
CTRE
$7.62B
| $4.73M | ﹤0.01% |
+230,593
| New | +$4.73M |
|
1095
Regency Centers
REG
$13B
| $4.72M | ﹤0.01% |
79,395
+63,568
| +402% | +$3.78M |
|
1096
Gibraltar Industries
ROCK
$1.78B
| $4.7M | ﹤0.01% |
69,565
-475
| -0.7% | -$32.1K |
|
1097
Metallus
MTUS
$697M
| $4.68M | ﹤0.01% |
215,699
-49,835
| -19% | -$1.08M |
|
1098
AdvanSix
ASIX
$576M
| $4.68M | ﹤0.01% |
150,720
+4,341
| +3% | +$135K |
|
|
WBA
1099
DELISTED
Walgreens Boots Alliance
WBA
| $4.67M | ﹤0.01% |
210,140
+91,577
| +77% | +$2.04M |
|
1100
OptimizeRx
OPRX
$322M
| $4.67M | ﹤0.01% |
600,393
+64,414
| +12% | +$501K |
|